Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Accelerating progress against gallbladder and bile duct cancers
Biliary tract cancers—rare malignancies arising in the gallbladder, bile ducts and related structures—are associated with poor outcomes.
Three checkpoint inhibitors reduce the risk of death for patients with hard-to-treat liver and biliary tract cancers.
Over a third of bile duct cancer patients treated with the kinase inhibitor experienced complete or partial tumor remission.
Incidence is increasing for six of 12 obesity-related cancers, including colorectal, kidney and pancreatic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.